Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
False and inaccurate information runs rampant online. But how much is it actually changing our behavior?
New study shows hospitalizations would fall by more than 50% and emergency department visits by over 30%.
Abrysvo vaccine reduce the risk of RSV hospitalization for babies by 57% during the first six months after birth.
According to the CDC, RSV is the leading cause of infant hospitalization in the U.S.
Americans’ choices, often informed by bad or misleading data, are among the causes of poor health.
But coverage still falls short of pre-pandemic levels, putting children at grave risk from disease outbreaks.
Adults ages 60 and older should discuss the new vaccines with their health care providers.
The share of kindergartners receiving the usual round of required vaccines dropped in the 2021-2022 school year.
Arexvy RSV vaccine is now approved for individuals age 60 and older.
Data suggest skepticism and misinformation surrounding COVID vaccines now threatens other public health priorities.
Vaccines are tested for safety, but like all medical products, they can sometimes cause side effects.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
A vaccine using mRNA technology induced an immune response in mice and ferrets against 20 different types of influenza.
Plus: Over 10 prevention services related to hepatitis, HIV and sexually transmitted infections covered by the Affordable Care Act.
What have we learned from the COVID-19 pandemic, and what’s the future of HIV vaccine research? Find out this #HVAD2022.
Are we fully vaccinated, even with a booster, or should we get a third shot to catch up with those who got Pfizer or Moderna?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.